Persistent Kirsten Rat Sarcoma (KRAS)-epidermal growth factor receptor (EGFR) pathway activation cooperates with TGFβ signaling to endow PDAC and TNBC tumor cells with chemoresistance, metastatic dissemination, and early recurrence [1,10,11,12]. The gene discussed is TGFB1; the disease is neoplasm.